|
Home | Medical-Newswire.Com:
|
(Medical-NewsWire.com, March 02, 2017 ) According to Publisher, the Global Stem Cell Banking Market is accounted for $1.42 billion in 2015 and is expected to reach $4.58 billion by 2022 growing at a CAGR of 18.2% during the forecast period. Growing number of newborns, increasing usage of stem cells in disorder treatment and rising disposable income are some of the factors fueling the market growth. However, huge operating price and regulatory changes are some of the factors hampering the market. Rising awareness about potential use of cord tissue and the automation of procedures are creating opportunities for vendors in the market.
For more information about this report: http://www.reportsweb.com/stem-cell-banking-global-market-outlook-2016-2022
Some of the key players in Stem Cell Banking market include Cordvida, International Stem Cell Corporation, BrainStorm Cell Therapeutics, ReeLabs, Gamida Cell, Cryo Stemcell, Medistem Inc, CordCare, RMS Regrow, Cellular Dynamics International, Arteriocyte, ReNeuron Group, Jeevan Blood Bank Research Center, RhinoCyte, Inc., Cytori Therapeutics, Inc. and StemOne Biologicals.
Applications Covered:
- Leukemia
- Cerebral Palsy
- Autism
- Thalassemia
- Diabetes
- Other Applications
Bank Types Covered:
- Cord Tissue
- Cord Blood
Service Types Covered:
- Analysis
- Collection & Transportation
- Storage
- Processing
Request Sample Copy at http://www.reportsweb.com/inquiry&RW0001564985/sample
Regions Covered:
- North America
o US
o Canada
o Mexico
- Europe
o Germany
o France
o Italy
o UK
o Spain
o Rest of Europe
- Asia Pacific
o Japan
o China
o India
o Australia
o New Zealand
o Rest of Asia Pacific
- Rest of the World
o Middle East
o Brazil
o Argentina
o South Africa
o Egypt
What our report offers:
- Market share assessments for the regional and country level segments
- Market share analysis of the top industry players
- Strategic recommendations for the new entrants
- Market forecasts for a minimum of 7 years of all the mentioned segments, sub segments and the regional markets
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements
Company Profiling
10.1 Cordvida
10.2 International Stem Cell Corporation
10.3 BrainStorm Cell Therapeutics
10.4 ReeLabs
10.5 Gamida Cell
10.6 Cryo Stemcell
10.7 Medistem Inc
10.8 CordCare
10.9 RMS Regrow
10.10 Cellular Dynamics International
10.11 Arteriocyte
10.12 ReNeuron Group
10.13 Jeevan Blood Bank Research Center
10.14 RhinoCyte, Inc.,
10.15 Cytori Therapeutics, Inc.
10.16 StemOne Biologicals
Inquire before Buying at http://www.reportsweb.com/inquiry&RW0001564985/buying
ReportsWeb.com
Priya Sisodia
+1-646-491-9876
sales@reportsweb.com
Source: EmailWire.Com 
Source: EmailWire.com
|
|
|
|
